# Nuclide record her2 (target). Data CC BY-NC 4.0, attribute "Data from Nuclide (nuclide.cc)". Whole corpus: https://nuclide.cc/api/v1/nuclide.nt
@prefix schema: <https://schema.org/> .
@prefix nuclide: <https://nuclide.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://nuclide.cc/targets/her2/>
  a schema:BioChemEntity ;
  nuclide:kind "target" ;
  schema:identifier "her2" ;
  schema:name "HER2"@en ;
  schema:description "A growth-signal receptor. Some cancers make far too much of it, and drugs that block it or use it as a docking site have transformed those cancers."@en ;
  schema:url <https://nuclide.cc/targets/her2/> ;
  schema:dateModified "2026-09-04"^^xsd:date ;
  schema:sameAs <https://en.wikipedia.org/wiki/HER2/neu>, <https://www.genenames.org/data/gene-symbol-report/#!/hgnc_id/HGNC:3430>, <https://www.ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000141736>, <https://www.uniprot.org/uniprotkb/P04626/entry>, <https://www.ncbi.nlm.nih.gov/gene/2064> ;
  schema:citation <https://en.wikipedia.org/wiki/HER2/neu> ;
  nuclide:tag "adc-target", "driver" ;
  schema:alternateName "ERBB2" ;
  nuclide:targetClass "surface-antigen" ;
  nuclide:indications <https://nuclide.cc/indications/breast-her2-positive/> ;
  nuclide:companies <https://nuclide.cc/companies/precirix/> ;
  nuclide:trials <https://nuclide.cc/trials/nct06369831/> .